Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells-Reference-Cited by-同舟云学术

Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells

Published:2013-06-04 Issue:10 Volume:133 Page:2464-2472
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Vives Marta¹,Ginestà Mireia M.¹,Gracova Kristina¹,Graupera Mariona²,Casanovas Oriol¹,Capellà Gabriel¹,Serrano Teresa³,Laquente Berta,Viñals Francesc

Affiliation:

1. Translational Research Laboratory; Catalan Institute of Oncology, IDIBELL, Hospital Duran i Reynals, L'Hospitalet de Llobregat; Barcelona; Spain

2. Molecular Oncology Department; Bellvitge Biomedical Research Institute, IDIBELL, L'Hospitalet de Llobregat; Barcelona; Spain

3. Anatomy and Pathology Department; University Hospital of Bellvitge, IDIBELL, L'Hospitalet de Llobregat; Barcelona; Spain

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?;Andre;Future Oncol,2011

2. Back to the basics: the importance of concentration × time in oncology;Weitman;J Clin Oncol,1993

3. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer;Browder;Cancer Res,2000

4. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity;Klement;J Clin Invest,2000

5. The anti-angiogenic basis of metronomic chemotherapy;Kerbel;Nat Rev Cancer,2004

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombospondin-1 in drug activity and tumor response to therapies;Seminars in Cell & Developmental Biology;2024-03

2. Cost-effectiveness of Metronomic chemotherapy vs Weekly Intravenous Paclitaxel in patients with ER+/HER2-Metastatic Breast Cancer;2024-01-23

3. A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine;Journal of Oncology Pharmacy Practice;2023-11-28

4. Metronomic chemotherapy in ovarian cancer;Cancer Letters;2023-11

5. Oral metronomic therapy of pancreatic cancer with gemcitabine and paclitaxel co-loaded in lecithin-based Self-Nanoemulsifying preconcentrate (LBSNEP);International Journal of Pharmaceutics;2023-10